Medication utilization for patients with chronic rhinosinusitis with nasal polyposis and asthma in 12 months pre- and post-dupilumab initiation

Emily Garvey,Bita Naimi,Alexander Duffy, Chase Kahn,Douglas Farquhar,Marc Rosen,Mindy Rabinowitz, Damaris Pena Evertz,Jessica Most,Elina Toskala,Gurston G. Nyquist

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY（2024）

引用 0|浏览3

暂无评分

摘要

Key Points This study examines the impact of dupilumab on medication use for chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma patients. Patients on dupilumab had a reduction in oral/inhaled/topical steroids, antibiotics, and leukotriene receptor antagonists (LTRAs). The reduction in medication use had no impact on total polyp or SNOT-22 scores.

查看译文

关键词

asthma,chronic rhinosinusitis,quality of life,steroid therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要